ARWR Insider Trading

Insider Ownership Percentage: 4.50%
Insider Buying (Last 12 Months): $54,990.00
Insider Selling (Last 12 Months): $11,140,210.56

Arrowhead Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Arrowhead Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arrowhead Pharmaceuticals Share Price & Price History

Current Price: $24.77
Price Change: Price Decrease of -0.23 (-0.92%)
As of 05/17/2024 09:53 PM ET

This chart shows the closing price history over time for ARWR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Arrowhead Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/2/2024Victoria VakienerDirectorSell1,799$23.31$41,934.6930,205View SEC Filing Icon  
3/20/2024Hongbo LuDirectorBuy1,000$27.50$27,500.0033,680View SEC Filing Icon  
3/18/2024Hongbo LuDirectorBuy1,000$27.49$27,490.0031,680View SEC Filing Icon  
3/6/2024Kenneth Allen MyszkowskiCFOSell40,000$35.19$1,407,600.00400,600View SEC Filing Icon  
1/31/2024Christopher Richard AnzaloneCEOSell57,499$32.35$1,860,092.653,715,048View SEC Filing Icon  
1/12/2024James C. HamiltonInsiderSell7,940$36.89$292,906.60210,851View SEC Filing Icon  
1/11/2024Douglas B GivenDirectorSell2,911$38.06$110,792.66129,711View SEC Filing Icon  
1/5/2024James C. HamiltonInsiderSell32,143$35.18$1,130,790.74218,791View SEC Filing Icon  
1/5/2024Kenneth Allen MyszkowskiCFOSell16,104$35.27$567,988.08440,600View SEC Filing Icon  
1/5/2024Patrick C. O'BrienCOOSell22,841$35.27$805,602.07464,385View SEC Filing Icon  
1/3/2024James C. HamiltonInsiderSell6,300$32.19$202,797.00175,934View SEC Filing Icon  
1/3/2024Patrick C. O'BrienCOOSell8,749$32.28$282,417.72403,826View SEC Filing Icon  
1/2/2024Christopher Richard AnzaloneCEOSell9,952$31.01$308,611.523,715,048View SEC Filing Icon  
12/20/2023Christopher Richard AnzaloneCEOSell12,000$28.54$342,480.003,725,000View SEC Filing Icon  
11/20/2023Javier San MartinInsiderSell19,700$28.80$567,360.00131,800View SEC Filing Icon  
10/25/2023Christopher Richard AnzaloneCEOSell24,338$24.21$589,222.983,737,000View SEC Filing Icon  
9/28/2023Victoria VakienerDirectorSell1,550$26.33$40,811.5021,734View SEC Filing Icon  
9/18/2023Christopher Richard AnzaloneCEOSell57,755$28.12$1,624,070.603,761,338View SEC Filing Icon  
7/3/2023Tracie OliverInsiderSell8,925$35.31$315,141.7561,575View SEC Filing Icon  
6/30/2023James C. HamiltonInsiderSell3,000$35.53$106,590.00188,484View SEC Filing Icon  
6/27/2023Kenneth Allen MyszkowskiCFOSell15,000$36.20$543,000.00381,704View SEC Filing Icon  
5/5/2023Douglas B GivenDirectorSell6,500$40.90$265,850.00117,635View SEC Filing Icon  
5/3/2023Christopher Richard AnzaloneCEOSell54,928$39.14$2,149,881.923,761,338View SEC Filing Icon  
3/3/2023Adeoye Y. OlukotunDirectorSell11,350$32.65$370,577.507,867View SEC Filing Icon  
2/27/2023Douglas B GivenDirectorSell875$32.62$28,542.5013,000View SEC Filing Icon  
1/9/2023William D. WaddillDirectorSell3,200$30.00$96,000.0028,950View SEC Filing Icon  
1/5/2023James C. HamiltonInsiderSell13,803$37.40$516,232.20191,484View SEC Filing Icon  
1/5/2023Patrick C. O'BrienCOOSell15,000$37.39$560,850.00413,375View SEC Filing Icon  
1/3/2023James C. HamiltonInsiderSell10,338$38.38$396,772.44145,287View SEC Filing Icon  
1/3/2023Patrick C. O'BrienCOOSell17,500$38.33$670,775.00363,375View SEC Filing Icon  
12/29/2022Kenneth Allen MyszkowskiCFOSell30,625$40.00$1,225,000.00336,704View SEC Filing Icon  
11/21/2022Javier San MartinInsiderSell19,500$29.99$584,805.0091,500View SEC Filing Icon  
2/11/2022Christopher Richard AnzaloneCEOSell146,388$51.91$7,599,001.08View SEC Filing Icon  
1/5/2022Kenneth Allen MyszkowskiCFOSell40,000$61.70$2,468,000.00View SEC Filing Icon  
1/5/2022Patrick C. O'BrienGeneral CounselSell32,500$61.72$2,005,900.00View SEC Filing Icon  
1/4/2022James C. HamiltonSVPSell19,375$65.49$1,268,868.75View SEC Filing Icon  
1/3/2022William D. WaddillDirectorSell4,500$64.72$291,240.00View SEC Filing Icon  
12/28/2021Douglas B GivenDirectorBuy655$66.37$43,472.35View SEC Filing Icon  
12/15/2021Christopher Richard AnzaloneCEOSell60,000$67.56$4,053,600.00View SEC Filing Icon  
11/19/2021Javier San MartinInsiderSell19,500$69.31$1,351,545.00View SEC Filing Icon  
10/22/2021Christopher Richard AnzaloneCEOSell50,000$65.63$3,281,500.00View SEC Filing Icon  
10/20/2021Christopher Richard AnzaloneCEOSell15,000$66.23$993,450.00View SEC Filing Icon  
9/13/2021Adeoye Y. OlukotunDirectorSell5,000$63.76$318,800.00View SEC Filing Icon  
6/24/2021Marianne De BackerDirectorSell5,000$89.85$449,250.00View SEC Filing Icon  
6/22/2021Douglass B. GivenDirectorSell4,500$89.21$401,445.00View SEC Filing Icon  
6/22/2021James HassardInsiderSell3,625$89.22$323,422.50View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Arrowhead Pharmaceuticals (NASDAQ:ARWR)

62.61% of Arrowhead Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ARWR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Arrowhead Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024Comerica Bank48,312$1.38M0.0%+11.2%0.039%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System122,486$3.50M0.0%+14.1%0.099%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC57,449$1.64M0.0%+21.3%0.046%Search for SEC Filing on Google Icon
5/16/2024Bayesian Capital Management LP25,303$0.72M0.1%N/A0.020%Search for SEC Filing on Google Icon
5/16/2024Silvercrest Asset Management Group LLC150,198$4.30M0.0%+49.9%0.121%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD71,136$2.04M0.0%+17.4%0.057%Search for SEC Filing on Google Icon
5/15/2024Avoro Capital Advisors LLC8,555,555$244.69M2.9%+657.1%6.889%Search for SEC Filing on Google Icon
5/15/2024Affinity Asset Advisors LLC120,000$3.43M0.4%N/A0.097%Search for SEC Filing on Google Icon
5/14/2024Capital International Investors479,106$13.70M0.0%-62.5%0.386%Search for SEC Filing on Google Icon
5/14/2024Natixis204,000$5.83M0.0%N/A0.164%Search for SEC Filing on Google Icon
5/14/2024CANADA LIFE ASSURANCE Co90,571$2.59M0.0%+9.8%0.073%Search for SEC Filing on Google Icon
5/14/2024American International Group Inc.220,217$6.30M0.0%+13.4%0.177%Search for SEC Filing on Google Icon
5/13/2024Evolutionary Tree Capital Management LLC44,896$1.28M1.3%-13.1%0.036%Search for SEC Filing on Google Icon
5/13/2024Seven Eight Capital LP75,224$2.15M0.2%+592.3%0.061%Search for SEC Filing on Google Icon
5/13/2024Ameritas Investment Partners Inc.38,867$1.11M0.0%+13.6%0.031%Search for SEC Filing on Google Icon
5/10/2024Ontario Teachers Pension Plan Board87,883$2.51M0.0%+1,239.3%0.071%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.12,404,050$354.76M0.0%+16.2%10.012%Search for SEC Filing on Google Icon
5/10/2024Gratus Wealth Advisors LLC12,250$0.35M0.1%N/A0.010%Search for SEC Filing on Google Icon
5/9/2024State Board of Administration of Florida Retirement System33,353$0.95M0.0%+14.2%0.027%Search for SEC Filing on Google Icon
5/8/2024ProShare Advisors LLC35,592$1.02M0.0%+21.7%0.029%Search for SEC Filing on Google Icon
5/8/2024US Bancorp DE43,796$1.25M0.0%-5.2%0.035%Search for SEC Filing on Google Icon
5/8/2024Russell Investments Group Ltd.242,636$6.94M0.0%-2.1%0.196%Search for SEC Filing on Google Icon
5/8/2024Headlands Technologies LLC2,417$69K0.0%+7,696.8%0.002%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Fundamental Investments LLC128,083$3.66M0.2%N/A0.103%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank243,300$6.96M0.0%+21.2%0.196%Search for SEC Filing on Google Icon
5/7/2024Nvwm LLC27,581$0.79M0.2%N/A0.022%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC7,355$0.21M0.0%-78.8%0.006%Search for SEC Filing on Google Icon
5/6/2024Texas Permanent School Fund Corp108,433$3.10M0.0%+17.3%0.088%Search for SEC Filing on Google Icon
5/3/2024Essex Investment Management Co. LLC72,299$2.07M0.4%N/A0.058%Search for SEC Filing on Google Icon
5/2/2024Mutual of America Capital Management LLC73,826$2.11M0.0%+11.5%0.060%Search for SEC Filing on Google Icon
5/2/2024Nordea Investment Management AB153,357$4.45M0.0%-1.8%0.124%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets116,091$3.32M0.0%-52.3%0.094%Search for SEC Filing on Google Icon
5/1/2024Oak Ridge Investments LLC41,932$1.20M0.1%-3.9%0.034%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.327,782$9.38M0.0%+67.2%0.265%Search for SEC Filing on Google Icon
4/30/2024Retirement Systems of Alabama348,784$9.98M0.0%+6.5%0.282%Search for SEC Filing on Google Icon
4/30/2024Commonwealth Equity Services LLC33,413$0.96M0.0%-1.5%0.027%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.484,120$13.85M0.0%+17.5%0.391%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.23,838$0.68M0.1%+91.8%0.019%Search for SEC Filing on Google Icon
4/26/2024Securian Asset Management Inc.10,100$0.29M0.0%+12.5%0.008%Search for SEC Filing on Google Icon
4/26/2024Yousif Capital Management LLC57,393$1.64M0.0%+9.9%0.046%Search for SEC Filing on Google Icon
4/25/2024New York State Teachers Retirement System138,683$3.97M0.0%+2.1%0.112%Search for SEC Filing on Google Icon
4/25/2024WCM Investment Management LLC225,583$6.45M0.0%+30.5%0.182%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.344,467$9.85M0.0%+796.9%0.278%Search for SEC Filing on Google Icon
4/23/2024Louisiana State Employees Retirement System35,700$1.02M0.0%+18.6%0.029%Search for SEC Filing on Google Icon
4/23/2024Amalgamated Bank64,664$1.85M0.0%-3.0%0.052%Search for SEC Filing on Google Icon
4/23/2024Wealth Effects LLC164,460$4.70M1.7%+1.6%0.133%Search for SEC Filing on Google Icon
4/19/2024State of Alaska Department of Revenue13,437$0.38M0.0%+16.1%0.011%Search for SEC Filing on Google Icon
4/18/2024Myecfo LLC18,497$0.53M0.3%N/A0.015%Search for SEC Filing on Google Icon
4/18/2024State of Michigan Retirement System30,470$0.87M0.0%+18.7%0.025%Search for SEC Filing on Google Icon
4/17/2024Hennion & Walsh Asset Management Inc.45,734$1.31M0.1%+11.0%0.037%Search for SEC Filing on Google Icon
4/12/2024Global Assets Advisory LLC40,242$1.15M0.0%N/A0.032%Search for SEC Filing on Google Icon
3/21/2024Healthcare of Ontario Pension Plan Trust Fund95,000$2.91M0.0%+63.8%0.077%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.10,672,076$326.57M0.0%-1.7%8.613%Search for SEC Filing on Google Icon
3/1/2024Goldman Sachs Group Inc.1,061,967$32.50M0.0%+136.6%0.857%Search for SEC Filing on Google Icon
2/28/2024American International Group Inc.194,208$5.94M0.0%-3.2%0.157%Search for SEC Filing on Google Icon
2/26/2024Neo Ivy Capital Management1,337$41K0.1%N/A0.001%Search for SEC Filing on Google Icon
2/20/2024Eventide Asset Management LLC313,289$9.59M0.2%N/A0.253%Search for SEC Filing on Google Icon
2/20/2024Quarry LP2,400$73K0.0%-51.6%0.002%Search for SEC Filing on Google Icon
2/14/2024Avidity Partners Management LP714,000$21.85M0.8%-32.9%0.576%Search for SEC Filing on Google Icon
2/14/2024Avoro Capital Advisors LLC1,130,000$34.58M0.5%+100.0%0.912%Search for SEC Filing on Google Icon
2/14/2024Sectoral Asset Management Inc.8,182$0.25M0.1%-94.8%0.007%Search for SEC Filing on Google Icon
2/13/2024Capital International Investors1,277,560$39.09M0.0%+55.2%1.031%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC365,087$11.17M0.0%+22.6%0.295%Search for SEC Filing on Google Icon
2/13/2024NEOS Investment Management LLC11,712$0.36M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/13/2024Campbell & CO Investment Adviser LLC15,961$0.49M0.0%N/A0.013%Search for SEC Filing on Google Icon
2/12/2024Eagle Asset Management Inc.553,860$16.95M0.1%+11.3%0.447%Search for SEC Filing on Google Icon
2/9/2024US Bancorp DE46,205$1.41M0.0%-2.0%0.037%Search for SEC Filing on Google Icon
2/9/2024Ontario Teachers Pension Plan Board6,562$0.20M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/9/2024Quest Partners LLC1,476$45K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/9/2024Corient Private Wealth LLC41,386$1.27M0.0%-1.5%0.033%Search for SEC Filing on Google Icon
2/9/2024UBS Group AG508,586$15.56M0.0%+37.6%0.410%Search for SEC Filing on Google Icon
2/9/2024Norges Bank1,321,927$40.45M0.0%N/A1.067%Search for SEC Filing on Google Icon
2/8/2024Panagora Asset Management Inc.85,262$2.61M0.0%-58.8%0.079%Search for SEC Filing on Google Icon
2/8/2024Fiera Capital Corp58,036$1.78M0.0%-1.7%0.054%Search for SEC Filing on Google Icon
2/8/2024Vanguard Personalized Indexing Management LLC10,085$0.31M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/8/2024Mitsubishi UFJ Asset Management Co. Ltd.8,714$0.28M0.0%+12.3%0.008%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC32,826$1M0.0%-71.3%0.031%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets243,605$7.45M0.0%+13.6%0.227%Search for SEC Filing on Google Icon
2/7/2024Teacher Retirement System of Texas23,556$0.72M0.0%-18.6%0.022%Search for SEC Filing on Google Icon
2/7/2024E Fund Management Co. Ltd.19,531$0.60M0.0%+27.7%0.018%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.845,979$25.89M0.0%+0.1%0.787%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank200,700$6.14M0.0%-10.1%0.187%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.21,833$0.67M0.0%-55.4%0.020%Search for SEC Filing on Google Icon
2/5/2024Van ECK Associates Corp2,395$73K0.0%+22.9%0.002%Search for SEC Filing on Google Icon
2/5/2024Retirement Systems of Alabama327,453$10.02M0.0%+0.1%0.305%Search for SEC Filing on Google Icon
2/5/2024Russell Investments Group Ltd.247,817$7.58M0.0%+10.5%0.231%Search for SEC Filing on Google Icon
2/2/2024State of New Jersey Common Pension Fund D86,532$2.65M0.0%-7.0%0.081%Search for SEC Filing on Google Icon
2/1/2024Yousif Capital Management LLC52,224$1.60M0.0%+3.3%0.049%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund40,600$1.24M0.0%-5.3%0.038%Search for SEC Filing on Google Icon
2/1/2024Handelsbanken Fonder AB21,600$0.66M0.0%+7.5%0.020%Search for SEC Filing on Google Icon
2/1/2024CWM LLC103,014$3.15M0.0%-5.2%0.096%Search for SEC Filing on Google Icon
1/31/2024Beaumont Financial Advisors LLC10,175$0.31M0.0%-4.2%0.009%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.7,430$0.23M0.0%-17.9%0.007%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio28,500$0.87M0.0%+7.1%0.027%Search for SEC Filing on Google Icon
1/29/2024Louisiana State Employees Retirement System30,100$0.92M0.0%N/A0.028%Search for SEC Filing on Google Icon
1/29/2024WCM Investment Management LLC172,865$5.36M0.0%+13.6%0.161%Search for SEC Filing on Google Icon
1/29/2024Friedenthal Financial1,670$51K0.0%N/A0.002%Search for SEC Filing on Google Icon
1/29/2024Wealth Effects LLC161,850$4.95M1.9%-1.8%0.151%Search for SEC Filing on Google Icon
1/26/2024Mutual of America Capital Management LLC66,229$2.03M0.0%-41.5%0.062%Search for SEC Filing on Google Icon
1/26/2024Moody Aldrich Partners LLC54,094$1.66M0.3%-9.3%0.050%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Arrowhead Pharmaceuticals logo
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes Plozasiran, which is in Phase 2b and one Phase 3 clinical trial to treat hypertriglyceridemia, mixed dyslipidemia, and chylomicronemia syndrome; Zodasiran that is in Phase 2b clinical trial for the treatment of dyslipidemia and hypertriglyceridemia; ARO-PNPLA3, which is in Phase 1 clinical trial to treat patients with non-alcoholic steatohepatitis; ARO-RAGE that is in Phase 1/2a clinical trial to treat inflammatory pulmonary conditions; and ARO-MUC5AC, which is in Phase 1/2a clinical trial to treat muco-obstructive pulmonary diseases. It also develops ARO-MMP7 that is in Phase 1/2a clinical trial for treatment of idiopathic pulmonary fibrosis; ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-SOD1 for the potential treatment of amyotrophic lateral sclerosis; and ARO-C3, which is in Phase 1/2a clinical trial for the treatment of patients with various complement mediated or complement associated renal diseases. In addition, the company is involved in the development of JNJ-3989, which is in Phase 2 clinical trial to treat chronic hepatitis B virus infection; Olpasiran that is in Phase 3 clinical trial to reduce the production of apolipoprotein A; GSK-4532990 that is in phase 2 clinical trial to treat liver diseases; HZN-457, which is in phase 1 clinical trial to treat uncontrolled gout; and Fazirsiran that is in Phase 3 clinical trial for the treatment for liver disease associated with alpha-1 antitrypsin deficiency. Arrowhead Pharmaceuticals, Inc. has license and research collaboration agreements with Janssen Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited; Horizon Therapeutics Ireland DAC; Amgen Inc.; and Glaxosmithkline Intellectual Property (No. 3) Limited. The company was founded in 2003 and is headquartered in Pasadena, California.
Read More on Arrowhead Pharmaceuticals

Today's Range

Now: $24.77
Low: $24.57
High: $25.64

50 Day Range

MA: $25.47
Low: $21.87
High: $29.40

52 Week Range

Now: $24.77
Low: $20.67
High: $39.83

Volume

710,600 shs

Average Volume

1,401,260 shs

Market Capitalization

$3.08 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.78

Who are the company insiders with the largest holdings of Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals' top insider shareholders include:
  1. Christopher Richard Anzalone (CEO)
  2. Patrick O'brien (COO)
  3. Kenneth Allen Myszkowski (CFO)
  4. James C Hamilton (Insider)
  5. Martin Javier San (Insider)
  6. Douglas B Given (Director)
  7. Tracie Oliver (Insider)
  8. Hongbo Lu (Director)
  9. Victoria Vakiener (Director)
  10. William D Waddill (Director)
  11. Adeoye Y Olukotun (Director)
Learn More about top insider investors at Arrowhead Pharmaceuticals.

Who are the major institutional investors of Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals' top institutional shareholders include:
  1. Vanguard Group Inc. — 10.01%
  2. Avoro Capital Advisors LLC — 6.89%
  3. Principal Financial Group Inc. — 0.39%
  4. Capital International Investors — 0.39%
  5. Retirement Systems of Alabama — 0.28%
  6. Assenagon Asset Management S.A. — 0.28%
Learn More about top institutional investors of Arrowhead Pharmaceuticals stock.

Which institutional investors are selling Arrowhead Pharmaceuticals stock?

During the last quarter, ARWR stock was sold by these institutional investors:
  1. Capital International Investors
  2. BNP Paribas Financial Markets
  3. SG Americas Securities LLC
  4. Evolutionary Tree Capital Management LLC
  5. Russell Investments Group Ltd.
  6. Walleye Trading LLC
  7. Nordea Investment Management AB
  8. US Bancorp DE
In the last year, company insiders that have sold Arrowhead Pharmaceuticals company stock include:
  1. Christopher Richard Anzalone (CEO)
  2. Patrick O'brien (COO)
  3. Kenneth Allen Myszkowski (CFO)
  4. James C Hamilton (Insider)
  5. Martin Javier San (Insider)
  6. Douglas B Given (Director)
  7. Tracie Oliver (Insider)
  8. Hongbo Lu (Director)
Learn More investors selling Arrowhead Pharmaceuticals stock.

Which institutional investors are buying Arrowhead Pharmaceuticals stock?

Within the last quarter, ARWR stock was acquired by institutional investors including:
  1. Avoro Capital Advisors LLC
  2. Vanguard Group Inc.
  3. Assenagon Asset Management S.A.
  4. Natixis
  5. Mirae Asset Global Investments Co. Ltd.
  6. Susquehanna Fundamental Investments LLC
  7. Affinity Asset Advisors LLC
  8. Ontario Teachers Pension Plan Board